Back to search
Sjögren's Syndrome
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Sjögren's Syndrome trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Sjögren's Syndrome trials you may qualify forThis is a Phase 2b, multicenter, randomized, double-blinded, placebo-controlled study to assess the efficacy and safety of IMVT-1402 in adult participants with…
Primary Sjögren's syndrome (pSS) can affect various organs, sometimes leads to life-threatening conditions and is always responsible for a decreased quality of…
Phase 3 Study of Telitacicept in Active Primary Sjögren's Disease (UPSTREAM SjD)
The primary objective of this study is to evaluate the long-term safety and tolerability of dazodalibep.
This prospective longitudinal study will be conducted in patients diagnosed with Sjögren's disease who are followed at the rheumatology outpatient clinic of Kah…
Unexplained fatigue is a frequent (60-70%) chronic complaint in Sjögren's syndrome (SjS) with a clear unmet therapeutic need, despite the recommendation of adap…
The purpose of this study is to measure the efficacy and safety of HZN-1116 in participants with Sjogren's syndrome (SS).
The purpose of this study is to measure the long-term safety and tolerability of ianalumab in participants with Sjögren's syndrome who have previously completed…
The main purpose of the proposed study is to evaluate the efficacy of efgartigimod PH20 SC in patients with moderate-to-severe Primary Sjögren's Disease (pSjD).…